Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study
PLOS One · 2025
DOI: 10.1371/journal.pone.0325287 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Wen Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Inflammation, Coronary Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fifth Batch of Hospital Key Discipline Construction Projects, Fujian Clinical Medical Research Center for Cardiac Macrovascular Diseases.
Abstract (Originalsprache)
Background
Increasing evidences indicate that systemic inflammation plays a significant role of adverse prognosis in patients with coronary heart disease (CHD). The inflammatory burden index (IBI) is a novel biomarker that reflects systemic inflammation. The aim of this study was to investigate the association between IBI and prognosis of CHD patients.
Methods
In this retrospective analysis, data from 2453 CHD patients enrolled from December 2017 to December 2022.IBI was defined as neutrophil/lymphocyte*C-reactive protein, with patients categorized into four groups based on quartiles of baseline IBI levels. The primary outcome was adverse cardiovascular and cerebrovascular events (MACCEs) occurring during hospitalization, which included repeat revascularization, new-onset atrial fibrillation (NOAF), stroke, and all-cause in-hospital mortality. Multivariate logistic regression models and restricted cubic spline (RCS) analysis were used to investigate the association between IBI and prognosis of CHD patients.
Results
High levels of IBI were associated with higher risk of MACCEs, especially when IBI ≥ 45.68, patients exhibited a higher risk of MACCEs ( P < 0.05). After adjusting for baseline confounders, multivariate logistic regression analysis demonstrated that baseline IBI was an independent predictor for NOAF (Odds Ratio (OR): 2.05; 95% confidence interval (CI): 1.30–3.24; P = 0.002) and contrast-induced nephropathy (CIN) (OR: 1.95; 95%CI: 1.16–3.28; P = 0.012) in CHD patients, mainly driven by the highest quartile. In addition, RCS confirmed a linear relationship between IBI and NOAF ( P for non-linear = 0.425) and a nonlinear relationship with CIN ( P for non-linear = 0.032).
Conclusion
IBI is a promising biomarker of systemic inflammation in CHD patients, where higher IBI levels are associated with adverse prognosis. These findings may aid clinicians in precise decision-making to improve outcomes in patients with CHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Nursing, Fujian Medical University, Fuzhou, Fujian, China.
- Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
- Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
- Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
- Fujian Provincial Special Reserve Talents Laboratory, Fuzhou, Fujian, China.
ORCID-Profile: Yanjuan Lin
Förderung
- the Fifth Batch of Hospital Key Discipline Construction Projects
- Fujian Clinical Medical Research Center for Cardiac Macrovascular Diseases
Zitieren
APA
Lu, W., Liao, X., Jiang, Y., Luo, B., Chen, L., & Lin, Y. (2025). Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study. PLOS One. https://doi.org/10.1371/journal.pone.0325287
Vancouver
Lu W, Liao X, Jiang Y, Luo B, Chen L, Lin Y. Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study. PLOS One. 2025. doi:10.1371/journal.pone.0325287
BibTeX
@article{Lu2025,
author = {Lu, Wen and Liao, Xiaoqin and Jiang, Yan and Luo, Baolin and Chen, Liangwan and Lin, Yanjuan},
title = {Association between inflammatory burden index and prognosis in patients with coronary heart disease: A retrospective study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0325287}
}
EUVIMED